La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Proterra Bilan de santé

Santé financière contrôle des critères 3/6

Proterra possède un total de capitaux propres de $275.2M et une dette totale de $179.0M, ce qui porte son ratio d'endettement à 65%. Son actif total et son passif total sont $711.4M et de $436.2M.

Informations clés

65.0%

Ratio d'endettement

US$178.99m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$130.71m
Fonds propres	US$275.21m
Total du passif	US$436.22m
Total des actifs	US$711.43m

Mises à jour récentes de la santé financière

Recent updates

Analysts Have Lowered Expectations For Proterra Inc. (NASDAQ:PTRA) After Its Latest Results

Mar 18

Is Proterra Stock Overvalued Or Undervalued? We're Boarding This Bus For More Upside

Sep 04

Proterra Is Promising But A Little Too Expensive

Jul 10

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de PTRA.Q ( $539.0M ) dépassent ses passifs à court terme ( $217.5M ).

Passif à long terme: Les actifs à court terme de PTRA.Q ( $539.0M ) dépassent ses passifs à long terme ( $218.7M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de PTRA.Q ( 17.5% ) est considéré comme satisfaisant.

Réduire la dette: Données insuffisantes pour déterminer si le ratio d'endettement de PTRA.Q a diminué au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: PTRA.Q dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: PTRA.Q dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 28.3 % chaque année

Proterra Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Proterra Inc. Files Form 15

Fourth Amended Joint Reorganization Plan and Disclosure Statement Filed by Proterra Inc.

Motion for Asset Sale Approved for Proterra Inc.

Nasdaq to Delist the Common Stock of Proterra

Proterra Inc. Receives Delisting Notice from Nasdaq

Motion for Joint Administration Filed by Proterra Inc.

Recent updates

Proterra Inc. Files Form 15

Fourth Amended Joint Reorganization Plan and Disclosure Statement Filed by Proterra Inc.

Proterra Inc. Announces CFO Changes

Proterra Inc. Announces Board Changes

Motion for Asset Sale Approved for Proterra Inc.

Proterra Inc. Announces Resignation of Julian Soell as Chief Operating Officer, Effective March 15, 2024

Nasdaq to Delist the Common Stock of Proterra

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Proterra, Inc

Proterra Inc.(OTCPK:PTRA.Q) dropped from NASDAQ Transportation Index

Rain Oncology Inc., Proterra Inc., Bioxcel Therapeutics, Inc Announces Class Action Update

Proterra Inc.(NasdaqGS:PTRA) dropped from S&P Global BMI Index

Proterra Inc. Announces Executive Appointments

Proterra Inc. Receives Delisting Notice from Nasdaq

Motion for Joint Administration Filed by Proterra Inc.

Proterra Inc. to Report Q2, 2023 Results on Aug 09, 2023

Levi & Korsinsky, LLP Files A Complaint to Recover Losses Suffered by Purchasers of Proterra Inc

Proterra Inc. Announces Appointment of Jeffrey Embt as Chief Accounting Officer

Proterra Inc. Announces Board Changes

First quarter 2023 earnings released: US$1.08 loss per share (vs US$0.23 loss in 1Q 2022)

Analysts Have Lowered Expectations For Proterra Inc. (NASDAQ:PTRA) After Its Latest Results

Price target decreased by 19% to US$6.00

No longer forecast to breakeven

Proterra Inc. Appoints Julian Soell as Chief Operating Officer and Chris Bailey as Chief Business Officer, Effective March 1, 2023

President recently sold US$113k worth of stock

Proterra Inc Produces Proterra Powered EV Battery At Its New Powered 1 Battery Manufacturing Plant Located in Greer, South Carolina

Forecast to breakeven in 2025

Chief Legal Officer exercised options and sold US$279k worth of stock

High number of new and inexperienced directors

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

Proterra Inc. to Report Q3, 2022 Results on Nov 02, 2022

Proterra Inc Appoints Sara Dadyar as Chief People Officer Effective October 17, 2022

Buy Proterra On Arrival's Downs

Proterra: Issues Abound

Second quarter 2022 earnings released: US$0.19 loss per share (vs US$4.24 loss in 2Q 2021)

Proterra Inc. Re-Affirms Revenue Guidance for the Full Year 2022

Proterra Inc. to Report Q2, 2022 Results on Aug 02, 2022

Price target decreased to US$6.90

Proterra Announces Appointment of Jan Hauser to Board of Directors

Price target decreased to US$6.88

High number of new and inexperienced directors

A Recession Would Make Proterra A Buy

Proterra: Holding Off For Now

Proterra Inc. Announces Appointment of Julian Soell as President of Proterra Transit Business Unit, Effective May 2, 2022

Proterra Inc., Annual General Meeting, May 26, 2022

Proterra Introduces ZX5 Electric Bus with 738 Kilowatt Hours of Energy

Proterra Inc., Annual General Meeting, May 26, 2022

Proterra Inc. announced delayed annual 10-K filing

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Proterra Inc. Announces Board Changes

Proterra Inc. to Report Q4, 2021 Results on Mar 01, 2022

Proterra's Road To Profitability Won't Be Easy

Price target decreased to US$12.00

Third quarter 2021 earnings released: EPS US$0.17 (vs US$10.11 loss in 3Q 2020)

CFO & Treasurer Amy Ard has left the company

Is Proterra Stock Overvalued Or Undervalued? We're Boarding This Bus For More Upside

Second quarter 2021 earnings released: US$4.24 loss per share (vs US$10.11 loss in 2Q 2020)

Proterra Is Promising But A Little Too Expensive

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines